Who Are the Top 3 Shareholders of Pfizer in 2024?

Discover the top 3 institutional shareholders of Pfizer, including Vanguard, BlackRock, and State Street, and their impact on the pharmaceutical giant.

190 views

As of the latest available information, the top 3 shareholders of Pfizer are: The Vanguard Group, Inc., BlackRock, Inc., and State Street Corporation. These institutional investors hold significant stakes in the company, reflecting confidence in Pfizer's business model and future prospects. Their involvement underscores the importance of Pfizer in the global pharmaceutical industry, especially during times of heightened demand for healthcare products and solutions.

FAQs & Answers

  1. Who are the largest shareholders of Pfizer? The largest shareholders of Pfizer are institutional investors The Vanguard Group, BlackRock, and State Street Corporation.
  2. How do institutional investors influence Pfizer? Institutional investors like Vanguard, BlackRock, and State Street hold significant stakes in Pfizer, influencing corporate governance and reflecting confidence in the company's future.
  3. Where can I find updated information on Pfizer shareholders? Updated shareholder information for Pfizer can be found in SEC filings such as the 13F forms and annual reports.
  4. Why are Pfizer's top shareholders important to investors? Top shareholders provide insight into the confidence major investors have in Pfizer, which can impact stock stability and market perception.